RBC keeps Digene at outperform

Digene Corp. was kept at an outperform rating, above average risk, by RBC Capital Markets analyst William R. Quirk following a quarterly channel check that revealed healthy testing volume growth (a 9% sequential growth). Trends remain ahead of RBC's expectations. The analyst is estimating 2007 revenue of $202.3 million. Shares of the Gaithersburg, Md.-based pharmaceutical company were up 69 cents, or 1.94%, at $36.23 on volume of 325,101 shares versus the three-month running average of 297,175 shares. (Nasdaq: DIGE)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.